Stock Region Watchlist
Gilead Buys Arcellx + Pizza Sales Surge 🍕
Stock Region: Your Monday Market Moves 🚀
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: The following information is for educational purposes only and does not constitute financial advice. Trading stocks involves risk, and it is important to always do your own research or consult with a qualified financial advisor before making any investment decisions. This content is not provided by a financial advisor, but by a market enthusiast sharing thoughts.
Happy Monday! Hope everyone had a fantastic weekend and recharged for the week ahead, because this one is kicking off with some serious fireworks. There’s a real buzz in the premarket action today. Massive buyouts, tough pills to swallow in the pharma world, and solid proof that everyone still loves a good pizza deal are all making headlines.
The market never sleeps, and neither does this community. Let’s dive into what’s moving the needle this morning, Monday, February 23, 2026.
1. Arcellx ($ACLX): The Jackpot Hit 💰
What’s Happening: Wow. Holding Arcellx over the weekend led to a big reason to smile this morning. Gilead Sciences just dropped the hammer and announced the acquisition of Arcellx for a whopping $7.8 billion. That translates to $115 per share in cash.
This is the kind of news traders wait for. It’s a massive premium and has sent the stock price soaring. It’s a huge validation for Arcellx’s tech and a bold move by Gilead.
Levels to Watch:
Upside: Above $115.60
Downside: Below $114.20
Takeaway: This is truly a “take the money and run” scenario. The deal is all cash, and the stock is trading right near the acquisition price. It’s exciting to see M&A activity heating up like this—it usually signals that big pharma is hungry for growth and willing to pay up for it. Anyone who caught this move deserves congratulations. For those considering entering now, chasing is not recommended; the easy money has already been made.
2. Novo Nordisk ($NVO): A Tough Pill to Swallow 📉
What’s Happening: On the flip side of the coin, Novo Nordisk is taking a serious beating. The stock is down over 15% this morning. Why? Their next-gen obesity drug, CagriSema, underperformed in trials compared to the competition.
This is a brutal setback. The market had high hopes that this drug would be the successor to Wegovy, but this news has effectively wiped out the recent gains. Investors are spooked about their competitive moat shrinking in the obesity market.
Levels to Watch:
Upside: Above $40.86
Downside: Below $40.26
Takeaway: Ouch. This one hurts to watch. It’s a classic reminder that biotech and pharma are high-risk games, even for the giants. A 15% drop for a company this size is massive. This could be an overreaction in the short term, but the long-term narrative has definitely taken a hit. Exercise great caution before trying to catch this falling knife until the dust settles. It feels like the market is punishing them for not being perfect, which happens when expectations are sky-high.
3. Domino’s Pizza ($DPZ): Comfort Food Wins 🍕
What’s Happening: Finally, some comfort food news. Domino’s Pizza crushed it! The company reported strong U.S. sales growth and beat revenue estimates for Q4.
It looks like Domino’s strategy to lure in budget-conscious customers with aggressive deals is working like a charm. People love a bargain, especially when it involves pepperoni. To top it off, the Board approved a 15% dividend hike—a huge vote of confidence in the company’s cash flow.
Levels to Watch:
Upside: Above $419.63
Downside: Below $398.46
Takeaway: This story stands out. In an economy where everyone is watching their wallet, Domino’s proves that convenience and value are king. A 15% dividend hike is aggressive and signals strong confidence from management about the company’s future. This isn’t just a pizza company; it’s a tech company that delivers food. The outlook here feels bullish—if sales can grow when consumers are being picky, imagine what happens when spending loosens up. Plus, a dividend raise is hard not to love.
It’s a mixed bag today—euphoria for Arcellx holders, panic for Novo investors, and steady gains for the pizza lovers. That’s the beauty of the market; there is always an opportunity somewhere.
Keep a close watch on the levels highlighted above. Volatility brings opportunity when risk is managed carefully.
Wishing everyone a successful trading week ahead!
— The Stock Region
Disclaimer: Stock Region is not a registered investment advisor. The content of this newsletter is provided for informational and entertainment purposes only. Please perform your own due diligence before making any investment decisions. Investments in securities involve the risk of loss. Past performance is not indicative of future results.